Get the Stockscreener App
2.26
4.63%
0.10
Pre-market:
2.26
Cibus Inc stock is traded at $2.26, with a volume of 507.45K.
It is up +4.63% in the last 24 hours and down -12.74% over the past month.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
See More
Previous Close:
$2.16
Open:
$2.15
24h Volume:
507.45K
Relative Volume:
2.90
Market Cap:
$69.60M
Revenue:
$1.82M
Net Income/Loss:
$-267.63M
P/E Ratio:
-0.1121
EPS:
-20.1639
Net Cash Flow:
$-50.53M
1W Performance:
+5.12%
1M Performance:
-12.74%
6M Performance:
-58.76%
1Y Performance:
-88.05%
1-Day Range:
$2.14
$2.7256
1-Week Range:
$1.91
$2.7256
52-Week Range:
$1.8036
$23.18
Cibus Inc Stock (CBUS) Company Profile
Name
Cibus Inc
Sector
Industry
Phone
(858) 450-0008
Address
6455 NANCY RIDGE DRIVE, SAN DIEGO
Compare CBUS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
2.26 | 69.60M | 1.82M | -267.63M | -50.53M | -20.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.92 | 129.14B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
680.61 | 74.41B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
581.21 | 35.31B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.75 | 31.30B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.57 | 27.35B | 3.32B | -860.46M | -1.04B | -8.32 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Initiated | Alliance Global Partners | Buy |
| Jul-19-24 | Resumed | Canaccord Genuity | Buy |
| Oct-09-23 | Initiated | H.C. Wainwright | Buy |
| Jul-19-23 | Resumed | Canaccord Genuity | Buy |
Cibus Inc Stock (CBUS) Latest News
Cibus (CBUS) Projected to Post Earnings on Thursday - Defense World
Cibus Achieves Another Milestone for a Durable White Mold Resistance Trait in Canola - CropLife
Cibus to Report Fourth Quarter 2024 Financial Results on March 20, 2025 After the Market Close and Host Conference Call - The Manila Times
Cibus, Inc. to Report Fourth Quarter 2024 Financial Results on March 20, 2025 - Nasdaq
Cibus to Report Fourth Quarter 2024 Financial Results on March 20, 2025 After the Market Close ... - Bluefield Daily Telegraph
Agricultural Biotech Leader Cibus Sets Q4 Earnings Date: Key Gene Editing Updates Expected - StockTitan
13,000 Shares in Cibus, Inc. (NASDAQ:CBUS) Purchased by IFP Advisors Inc - Defense World
Cibus Inc (CBUS) Shares Soar Above 1-Year High - The News Heater
Cibus’s Strategic Advancements and Leadership Transition Drive Buy Rating - TipRanks
Cibus' Achieves Another Milestone for a Durable White Mold (Sclerotinia) Resistance Trait in Canola - The Manila Times
Can Cibus' Gene-Edited Canola Traits Revolutionize Crop Disease Management? - StockTitan
Cibus Announces Leadership Transition and CEO Succession Plan - Seed World
Cibus, Inc. Announces CEO Changes -February 28, 2025 at 08:30 am EST - Marketscreener.com
Cibus Appoints Peter Beetham as Interim CEO - TipRanks
Cibus Announces Leadership Change and CEO Succession Plan - The Manila Times
Who's Taking the Helm at Cibus? Inside the Leadership Shakeup During Critical Commercialization Phase - StockTitan
Cibus director Gerhard Prante sells $2,208 in stock By Investing.com - Investing.com Australia
Levi & Korsinsky Announces an Investigation on Behalf of Cibus, Inc. (CBUS) Shareholders Who May Have Been Affected by Fraud - ACCESS Newswire
Cibus director Gerhard Prante sells $2,208 in stock - Investing.com India
Cibus director Gerhard Prante sells $2,380 in stock - Investing.com India
Cibus director Gerhard Prante sells $2,380 in stock By Investing.com - Investing.com Australia
Cibus director Gerhard Prante sells $2,530 in stock - Investing.com India
Cibus director Gerhard Prante sells $2,530 in stock By Investing.com - Investing.com South Africa
Cibus director Gerhard Prante sells $2,702 in stock By Investing.com - Investing.com Australia
Cibus director Gerhard Prante sells $2,702 in stock - Investing.com India
Cibus director Gerhard Prante sells $2,967 of stock By Investing.com - Investing.com Nigeria
Short Interest in Cibus, Inc. (NASDAQ:CBUS) Declines By 8.7% - MarketBeat
Cibus director Gerhard Prante sells $2,967 of stock - Investing.com
Cibus, Inc. (NASDAQ:CBUS) Sees Large Decline in Short Interest - Defense World
Cibus director Prante sells $2,875 in stock By Investing.com - Investing.com Nigeria
Cibus director Gerhard Prante sells $2,990 in stock By Investing.com - Investing.com Nigeria
Cibus director Gerhard Prante sells $2,990 in stock - Investing.com
Cibus director Prante Gerhard sells $2,875 in stock - MSN
Cibus director Gerhard Prante sells $2,909 in stock - MSN
Cibus director Gerhard Prante sells $2,909 in stock By Investing.com - Investing.com Australia
Cibus director Gerhard Prante sells $2,817 in stock - MSN
Cibus director Prante sells $2,875 in stock - MSN
Cibus Announces Important Update to Rice Gene Editing Conversion Rates - The Manila Times
Cibus, Inc. Issues Correction on Rice Gene Editing Conversion Rates and Updates on Technological Advances - Nasdaq
Research Setback: Cibus Unable to Replicate Promising Gene Editing Results in Rice - StockTitan
Cibus director Gerhard Prante sells $5,531 in stock - MSN
Cibus Inc Stock (CBUS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.39%
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):